版本:
中国

BRIEF-FDA grants Roche label extension for cobas EGFR mutation test

Sept 29 Roche Holding AG

* FDA grants Roche label extension for cobas egfr mutation test v2 for use with plasma as a companion diagnostic for Tagrisso

* FDA approved a label extension of cobas egfr mutation test v2 for use with plasma samples as a companion diagnostic for Astra Zeneca's non-small cell lung cancer (nsclc) therapy Tagrisso Source text for Eikon: Further company coverage: (Reporting By Michael Shields)

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐